Avanir Pharmaceuticals

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit http://www.avanir.com. Avanir is a subsidiary of Otsuka America, Inc. (OAI), a holding company established in the U.S. in 1989. OAI is wholly owned by Otsuka Pharmaceutical Co., Ltd. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide. Avanir® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.
Type
Subsidiary
Parent Company
Otsuka Pharmaceutical
HQ
Aliso Viejo, US
Founded
1988
Size (employees)
527 (est)+19%
Avanir Pharmaceuticals was founded in 1988 and is headquartered in Aliso Viejo, US

Avanir Pharmaceuticals Office Locations

Avanir Pharmaceuticals has offices in Aliso Viejo, , New York
Aliso Viejo, US
New York, US

Avanir Pharmaceuticals Metrics

Avanir Pharmaceuticals Summary

Founding Date

1988

Total Funding

$30 M

Investors

Avanir Pharmaceuticals is a subsidiary of Otsuka Pharmaceutical

Avanir Pharmaceuticals Company Life

You may also be interested in